| Bextra
litigation Philadelphia.
If
you are currently on Bextra check with your doctor, especially
if you have a history of heart problems.
Withdrawal
On
April 7, 2005 the FDA announced that it has asked Pfizer, Inc.
to withdraw Bextra from the
market "because the overall risk versus benefit profile for
the drug is unfavorable."
Recently Bextra® has added warnings
to it's box strengthening previous warnings about the risk of life-threatening
skin reactions and a new bolded warning contraindicating
it's use for patients undergoing coronary artery bypass surgery.
Now the FDA has asked its maker to withdraw it from the market.
Bextra® is a non-steroidal anti-inflammatory drug
(NSAIDs), known as a COX-2 selective agent. It is
prescribed for inflammation and pain from arthritis or menstrual
cramping. Other drugs in this class include Celebrex® and
Vioxx®. Bextra® and Celebrex® are both marketed by
Pharmacia Corporation and Pfizer
and Vioxx® is manufactured by Merck. Some doctors switched patients
from Vioxx® to Bextra® when Merck voluntarily removed it from the
market due studies showing an increased risk for heart attack
and stroke.
bextra
site map
Autism
Education Materials!
|
